About Us > Jennifer Winn, MD, MS

Jennifer Winn, MD, MS

Highlights

  • Attending physician of hematology/oncology and assistant professor of medical oncology at Fox Chase Cancer Center
  • Board certified in medical oncology, hematology and internal medicine
featured_paragraph

Jennifer Winn, MD, MS, is an attending physician of hematology/oncology and assistant professor of medical oncology at Fox Chase Cancer Center in Philadelphia.

general_content

Dr. Winn is board certified in medical oncology, hematology and internal medicine. She has a research interest in hormone receptor-positive breast cancer and invasive lobular cancers.

contributions_carousel

Contributions

Types of hormonal therapy

05/23/23 | BY: Jennifer Winn

Hormonal therapy medicines are in classes based on how they interact with the body’s natural hormones estrogen & progesterone. Some stop the body from making estrogen; others prevent estrogen from helping the cancer cell grow

Read More
 | 6 Min. Read |

Hormonal therapy

05/04/18 | BY: Jennifer Winn, M. Tish Knobf, Ann H. Partridge, Edith Perez, Betty Harris, Katharine Campbell, Betsy Clark

Hormonal therapy is using medicine or surgery to reduce estrogen in the body for cancers that depend on estrogen or progesterone to grow.

Read More
 | 3 Min. Read |

What is hormonal therapy?

05/04/18 | BY: Katharine Campbell, Betsy Clark, Betty Harris, M. Tish Knobf, Ann H. Partridge, Edith Perez, Jennifer Winn

Hormonal therapy for breast cancer interferes with the signals that hormone receptors send to cells and may block estrogen receptors, reduce the amount of estrogen made, or lessen the number of hormone receptors.

Read More
 | 7 Min. Read |

Fulvestrant

01/26/18 | BY: Jennifer Winn

Fulvestrant (Faslodex) is an estrogen receptor antagonist, or ERA, a class of medicine that stops the activity of estrogen on cancer cells to keep them from growing.

Read More
 | 4 Min. Read

Importance of menopausal status

08/31/15 | BY: Jennifer Winn, M. Tish Knobf, Ann H. Partridge, Edith Perez, Betty Harris, Katharine Campbell, Betsy Clark

Read More
 | 5 Min. Read

Common questions

08/31/15 | BY: Jennifer Winn, M. Tish Knobf, Ann H. Partridge, Edith Perez, Betty Harris, Katharine Campbell, Betsy Clark

Many women have these common questions about hormonal therapy, but you may have others as well.

Read More
 | 6 Min. Read |

Aromatase inhibitors

08/31/15 | BY: Jennifer Winn

The aromatase inhibitors, or AIs, are medicines that reduce the risk of breast cancer returning in postmenopausal women with hormone receptor-positive, early-stage breast cancer. They are also a standard treatment for MBC.

Read More
 | 6 Min. Read |

Megestrol acetate

08/31/15 | BY: Jennifer Winn

Megestrol acetate is a progestin hormonal therapy. Progestins are human-made medicines that act like the natural hormone progesterone.

Read More
 | 4 Min. Read |

Toremifene citrate

08/31/15 | BY: Jennifer Winn

Toremifene citrate is a hormonal therapy that is FDA approved to treat hormone receptor-positive metastatic breast cancer. It is a medicine that prevents estrogen signals from getting to breast cancer cells.

Read More
 | 4 Min. Read